VPT Stock Overview
A medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Ventripoint Diagnostics Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.14 |
| 52 Week High | CA$0.36 |
| 52 Week Low | CA$0.12 |
| Beta | 0.39 |
| 11 Month Change | -10.00% |
| 3 Month Change | -30.77% |
| 1 Year Change | -6.90% |
| 33 Year Change | -62.50% |
| 5 Year Change | 42.11% |
| Change since IPO | -96.63% |
Recent News & Updates
Recent updates
Shareholder Returns
| VPT | CA Medical Equipment | CA Market | |
|---|---|---|---|
| 7D | -3.6% | 1.8% | 1.3% |
| 1Y | -6.9% | 5.5% | 23.1% |
Return vs Industry: VPT underperformed the Canadian Medical Equipment industry which returned 5.5% over the past year.
Return vs Market: VPT underperformed the Canadian Market which returned 23.1% over the past year.
Price Volatility
| VPT volatility | |
|---|---|
| VPT Average Weekly Movement | 12.0% |
| Medical Equipment Industry Average Movement | 13.2% |
| Market Average Movement | 8.3% |
| 10% most volatile stocks in CA Market | 17.8% |
| 10% least volatile stocks in CA Market | 2.9% |
Stable Share Price: VPT has not had significant price volatility in the past 3 months compared to the Canadian market.
Volatility Over Time: VPT's weekly volatility (12%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | n/a | Hugh MacNaught | ventripoint.com |
Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. It offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient’s heart chambers. The company also provides VMS+ software, a 2D and 3D ultrasound models.
Ventripoint Diagnostics Ltd. Fundamentals Summary
| VPT fundamental statistics | |
|---|---|
| Market cap | CA$21.05m |
| Earnings (TTM) | -CA$5.02m |
| Revenue (TTM) | CA$72.07k |
303.3x
P/S Ratio-4.4x
P/E RatioIs VPT overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| VPT income statement (TTM) | |
|---|---|
| Revenue | CA$72.07k |
| Cost of Revenue | CA$6.75k |
| Gross Profit | CA$65.32k |
| Other Expenses | CA$5.09m |
| Earnings | -CA$5.02m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.031 |
| Gross Margin | 90.64% |
| Net Profit Margin | -6,966.13% |
| Debt/Equity Ratio | -46.1% |
How did VPT perform over the long term?
See historical performance and comparison